OHSU in the news

Portland nutritionist says FDA ban on Red Dye No. 3 is long overdue

KPTV January 16, 2025
Diane Stadler, Ph.D., R.D.N., shares insight on the FDA's recent ban of Red Dye No. 3. She says, “I think it takes the public being aware of the concerns and supporting organizations that serve as watchdog organizations that promote health for the citizens of our country. I can’t explain why it’s taken this long but I just think it has not been raised to the level of urgency and priority, sometimes once it hits that recognition that this is something we can change."

Project to amass databases describing gene expression, regulation and genetics data from birth to adolescence

Medical Xpress January 16, 2025
OHSU will lead a new database project designed to track the normal expression of genes in organs and tissues from prenatal development through adulthood, a process called Genotype-Tissue Expression. Victoria Roberts, Ph.D., says, “The goal is to assemble a vast base of knowledge about how genes are expressed in the normal course of development. When you know what’s normal, then you can look at what’s abnormal in diseases and pathologies and, ultimately, develop new tools to treat or prevent those conditions.”

Oregon State receives $11.9 million from Defense Department to enhance health of armed forces

Columbia Gorge News January 15, 2025
OHSU is noted as a contributor in coverage of an $11.9 million grant from the Department of Defense Hermes program to Oregon State University to invent new drug delivery technologies for protecting members of the military from a range of health threats in combat areas. Gaurav Sahay, Ph.D., says, “To do what the Hermes program is looking for, we need to enable intracellular delivery of messenger RNA to diverse cell and tissue types while overcoming the negative side effects and other challenges associated with broad systemic delivery.”

OHSU scientists reveal way to turn on hibernation in rats, pointing to possible future therapy in humans

Oregon Public Broadcasting January 15, 2025
Domenico Tupone, Ph.D., joins OPB-Radio's Think Out Loud to share insight from a recent study looking at hibernation in rats, raising questions about how these methods could be used in non-hibernating species, including humans. He says, "So what we have done in these rats is we have blocked the activity of the original thermostat, the one that will respond normally to cold and warm ambient, and allow us to maintain our body temperature. And when we have done so, we discovered that the system is now responding in a completely different way."

Online Therapy Boom Has Mainly Benefited Privileged Groups, Studies Find

The New York Times January 15, 2025
As telehealth platforms grow, they may be attracting clinicians from community settings with the promise of flexible hours and better conditions, said Dr. Jane M. Zhu, an associate professor of medicine at Oregon Health and Science University who studies the accessibility of mental health services.

Oregon State University receives $11.9M for military drug research

The News-Review January 14, 2025
OHSU is noted as a contributor in coverage of an $11.9 million grant from the Department of Defense Hermes program to Oregon State University to invent new drug delivery technologies for protecting members of the military from a range of health threats in combat areas. Gaurav Sahay, Ph.D., says, “To do what the Hermes program is looking for, we need to enable intracellular delivery of messenger RNA to diverse cell and tissue types while overcoming the negative side effects and other challenges associated with broad systemic delivery.”

Oregon State University secures $11.9M for potential life-saving drug tech for soldiers

Central Oregon Daily News January 14, 2025
OHSU is noted as a contributor in coverage of an $11.9 million grant from the Department of Defense Hermes program to Oregon State University to invent new drug delivery technologies for protecting members of the military from a range of health threats in combat areas. Gaurav Sahay, Ph.D., says, “To do what the Hermes program is looking for, we need to enable intracellular delivery of messenger RNA to diverse cell and tissue types while overcoming the negative side effects and other challenges associated with broad systemic delivery.”
See more stories